Navigation Links
NUCRYST Announces First Quarter 2008 Financial Results
Date:5/6/2008

WAKEFIELD, MA, May 6 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced its financial results for the first quarter ended March 31, 2008. Total revenues were $5.2 million for the first quarter of 2008, as compared with $5.2 million in the first quarter of 2007. Total revenues in the first quarter 2008 include wound care product revenues of $6.3 million, a 21% increase from $5.2 million in the first quarter of 2007, which was offset by the recognition during the quarter of $1.1 million of a $4.5 million manufacturing cost rebate paid annually to Smith & Nephew under our supply agreement.

Net loss for the first quarter of 2008 was $2.2 million, or $0.12 per share, compared to a net loss of $1.9 million, or $0.10 per share, for the same period last year. As of March 31, 2008, NUCRYST had $23.2 million in cash and cash equivalents, as compared to $17.8 million on December 31, 2007. Further financial information follows at the end of the release.

"We are highly focused on strengthening our core business and we continue to pursue additional opportunities for our nanocrystalline silver based products," said Thomas E. Gardner, Chairman and Chief Executive Officer of NUCRYST. "In addition, we are continuing our focus on improving operating efficiencies and have recently announced further steps to reduce costs, including consolidating management of our research and development organization."

First Quarter 2008 Financial Detail

For the quarter ended March 31, 2008, NUCRYST reported total revenues of $5.2 million, flat over the same period in 2007. Wound care product revenues in the first quarter of 2008 were $6.3 million, an increase of 21% from the same period in 2007. The increase in revenues is primarily due to increased manufacturing cost reimbursement received from Smith & Nephew driven by increased product orders received from and ship
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. NUCRYST Announces Management Realignment and R&D Portfolio Change
2. NUCRYST Announces Senior Management Change
3. NUCRYST Pharmaceuticals announces year-end results
4. NUCRYST Pharmaceuticals announces 2007 third quarter results
5. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
6. NUCRYST and Smith & Nephew Revise Agreements
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Bank of America Healthcare Conference
8. NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program
9. WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering
10. Rigel Announces First Quarter 2008 Financial Results
11. BioForm Medical Announces Extension of Lock-Up Period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... October 22, 2014 The ... which is dedicated to distribute health information technology ... delivery worldwide announced the development of six key ... expect when receiving healthcare. These are an expansion ... care: “providing care that is respectful of and ...
(Date:10/22/2014)... Best Cheap Hosting USA is among the most distinguished ... announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is the best ... world. , “iPower is one of the most reliable ... kinds of useful products for new and old clients. ... service and a number of features which will appeal ...
(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... fertilization (IVF) are only about half as likely as white ... new research indicates, and the racial disparity persists even when ... percent of white patients became pregnant after IVF, compared to ... 4,000 IVF cycles over two years to tease out the ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
... country's greenest and cleanest city was not enough, Chandigarh is all ... become the first smoke-free city in the country. ... free by July 1. ,The joint capital of Punjab ... and buildings to ensure that smoking is restricted and the general ...
... a million less AIDS patients than has been widely believed, ... were reported here. ,The survey that was ... out under international supervision shows that India probably no longer ... the New York Times said Friday. ,An official ...
... epilepsy in developing countries are being denied an effective ... according to an editorial in this weeks BMJ. ... in developing countries to ensure that effective treatment is ... people with epilepsy who live in developing countries, around ...
... (hESC), those very young cells that are a biological blank ... to the workings of a wide variety of organs and ... slow to be realized because of the ongoing ethical debate ... its a politically charged issue in the U.S. because it ...
... of tumors and the response of tumors to radiation ... in turn limits oxygen delivery to the tumor, causing ... shown to trigger tumor resistance to radiation via the ... known as HIF-1regulated cytokines. In a study appearing online ...
... community hospita,l in Detroit with 285 beds, specializing in general ... failure, diabetes and obstetrics. ,Detroit is the largest ... a prosperous region. ,But Riverview is all ... week said it was losing too much money and already ...
Cached Medicine News:Health News:Chandigarh to Become India's First Smoke-free City 2Health News:India Has a Million Less AIDS Cases Than Believed: Study 2Health News:Dartmouth Professor Makes Case for Ethically Universal Stem Cell Lines 2Health News:Hospitals in Older Cities Close Down, Blacks Worst Affected 2Health News:Hospitals in Older Cities Close Down, Blacks Worst Affected 3
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
(Date:10/20/2014)... MOUNTAIN VIEW, Calif. , Oct. 20, 2014 /PRNewswire/ ... field of interventional pulmonology, today announced completion of enrollment ... schedule.  The RENEW Clinical Study is the FDA-approved IDE ... treatment for severe emphysema. It was anticipated ... US in February 2013, would take until the end ...
(Date:10/20/2014)... 2014 Valeritas, Inc., a leader in simple, ... Type 2 diabetes, announced today that it has received ... award was presented October 16 th at Cardinal,s ... . The Cardinal Health Supply ... of metrics specifically targeted at the importance of developing ...
Breaking Medicine Technology:Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3
... Aug. 1, 2011 Biodel Inc. (Nasdaq: BIOD ... results on August 4, 2011.  Following the release of the ... call to discuss the results and provide an update on ... fiscal year 2011 results will be distributed4:15 pm EDT: , ...
... 2011 Reportlinker.com announces that a new ... catalogue: Insulin- Global ... This package contains 63 insulin market analyses ... Czech Republic,Denmark, Estonia, Finland, France, Germany, Greece, ...
Cached Medicine Technology:Insulin- Global 2
... As the leader in liquid handling, ... Finnpipette Novus, a pipette that combines simplicity, ... ergonomic design. Built on the results of ... the new Finnpipette Novus gives you the ...
... The StaRRsed-III is a system ... human blood samples. This rate may ... patients therapy. The sedimentation rate is ... hence is typically used in high-volume ...
... complete range of automatic systems for performing ... mL of blood. With the introduction of ... clinical diagnostic market a truly revolutionary testing ... limitation associated with the traditional ESR techique.,By ...
... The NEW VACUETTE erythrocyte sedimentation ... can help. The new generation unites ... analysers with whole range of additional ... of the erythrocyte sedimentation rate. Cost ...
Medicine Products: